Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03518515 · ClinicalTrials.gov registry record · NA

Potato Consumption and Energy Balance

A NA study of Obesity, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT03518515 is a NA study of Obesity that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 180 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03518515, a NA study of Obesity, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

A randomized, clinical trial will be performed to assess changes in body weight and fat mass with daily potato consumption versus a calorie-matched snack of almonds.

Conditions Studied

Interventions

  • OTHER Almond
  • OTHER White potato (french fries)
  • OTHER White potato (French fries), +seasoning

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2018-08-02
Est. Completion 2020-03-18
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03518515

The ClinicalTrials.gov registry entry for NCT03518515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Almond is the first listed.

NCT03518515 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03518515 about?

NCT03518515 is a clinical study titled "Potato Consumption and Energy Balance". A randomized, clinical trial will be performed to assess changes in body weight and fat mass with daily potato consumption versus a calorie-matched snack of almonds.

What is the current status of trial NCT03518515?

This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2018-08-02. Estimated completion is 2020-03-18.

What conditions does trial NCT03518515 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03518515?

The interventions under investigation include: Almond (OTHER), White potato (french fries) (OTHER), White potato (French fries), +seasoning (OTHER).

Who is sponsoring clinical trial NCT03518515?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03518515 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.